| Jaime Ungo, MD | |
|
860 S Madison St, Tupelo, MS 38801-4905 | |
| (662) 377-7150 | |
| (662) 377-7155 |
| Full Name | Jaime Ungo |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 33 Years |
| Location | 860 S Madison St, Tupelo, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275599656 | NPI | - | NPPES |
| 00119862 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 16034 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Mississippi Medical Ctr Hha | Tupelo, MS | Home health agency |
| North Mississippi Medical Center | Tupelo, MS | Hospital |
| Clay County Medical Corporation | West point, MS | Hospital |
| Tishomingo Health Services Inc | Iuka, MS | Hospital |
| Pontotoc Health Service Inc Cah | Pontotoc, MS | Hospital |
| Webster General Hospital/ Swing Bed | Eupora, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Mississippi Medical Center Inc | 9931010600 | 295 |
News Archive
A treatment combining two antibodies (casirivimab and imdevimab) is recommended for two specific groups of patients with covid-19 by a WHO Guideline Development Group (GDG) panel of international experts and patients in The BMJ today.
Scientists have identified a mysterious culprit that threatens headaches, stuffy noses, skin rash and other allergy symptoms when more than 500 million people worldwide drink wine. The discovery could help winemakers in developing the first low allergenic vintages - reds and whites with less potential to trigger allergy symptoms, they say. The new study appears in ACS' monthly Journal of Proteome Research.
Covidien plc today reported results for the first quarter of fiscal 2010 (October – December 2009). First-quarter net sales of $2.7 billion were up 7% from the $2.6 billion reported a year ago, with favorable foreign exchange of $121 million increasing the quarterly sales growth rate by approximately 5 percentage points.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that on November 18, 2009 the Compensation Committee of the Company's Board of Directors granted an inducement stock option to purchase 200,000 shares of common stock to Preston Klassen, M.D., its newly appointed Head of the Global Contrave Program.
› Verified 9 days ago
| Entity Name | North Mississippi Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972608347 PECOS PAC ID: 9931010600 Enrollment ID: O20040413000541 |
News Archive
A treatment combining two antibodies (casirivimab and imdevimab) is recommended for two specific groups of patients with covid-19 by a WHO Guideline Development Group (GDG) panel of international experts and patients in The BMJ today.
Scientists have identified a mysterious culprit that threatens headaches, stuffy noses, skin rash and other allergy symptoms when more than 500 million people worldwide drink wine. The discovery could help winemakers in developing the first low allergenic vintages - reds and whites with less potential to trigger allergy symptoms, they say. The new study appears in ACS' monthly Journal of Proteome Research.
Covidien plc today reported results for the first quarter of fiscal 2010 (October – December 2009). First-quarter net sales of $2.7 billion were up 7% from the $2.6 billion reported a year ago, with favorable foreign exchange of $121 million increasing the quarterly sales growth rate by approximately 5 percentage points.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that on November 18, 2009 the Compensation Committee of the Company's Board of Directors granted an inducement stock option to purchase 200,000 shares of common stock to Preston Klassen, M.D., its newly appointed Head of the Global Contrave Program.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jaime Ungo, MD 860 S Madison St, Tupelo, MS 38801-4905 Ph: (662) 377-7150 | Jaime Ungo, MD 860 S Madison St, Tupelo, MS 38801-4905 Ph: (662) 377-7150 |
News Archive
A treatment combining two antibodies (casirivimab and imdevimab) is recommended for two specific groups of patients with covid-19 by a WHO Guideline Development Group (GDG) panel of international experts and patients in The BMJ today.
Scientists have identified a mysterious culprit that threatens headaches, stuffy noses, skin rash and other allergy symptoms when more than 500 million people worldwide drink wine. The discovery could help winemakers in developing the first low allergenic vintages - reds and whites with less potential to trigger allergy symptoms, they say. The new study appears in ACS' monthly Journal of Proteome Research.
Covidien plc today reported results for the first quarter of fiscal 2010 (October – December 2009). First-quarter net sales of $2.7 billion were up 7% from the $2.6 billion reported a year ago, with favorable foreign exchange of $121 million increasing the quarterly sales growth rate by approximately 5 percentage points.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that on November 18, 2009 the Compensation Committee of the Company's Board of Directors granted an inducement stock option to purchase 200,000 shares of common stock to Preston Klassen, M.D., its newly appointed Head of the Global Contrave Program.
› Verified 9 days ago
Dr. Marcus Louis Britton, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1542 Medical Park Cir, Tupelo, MS 38801 Phone: 662-844-4711 | |
John O Phillips, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 589 Garfield St, Suite 201, Tupelo, MS 38801 Phone: 662-680-5565 Fax: 662-680-5654 | |
Dr. Michael Ted Boler Jr., D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 499 Gloster Creek Vlg Ste A2, Tupelo, MS 38801 Phone: 662-620-6800 Fax: 662-620-6950 | |
Christy Tucker Oswalt, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 65 S Thomas St, Tupelo, MS 38801 Phone: 662-842-7870 Fax: 662-842-7873 | |
Vernon A Rayford, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 845 S Madison St, Tupelo, MS 38801 Phone: 662-377-5930 | |
Stephen T Amann, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 589 Garfield St, Tupelo, MS 38801 Phone: 662-680-5565 Fax: 662-680-5654 | |
Douglas L Hill, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 499 Gloster Creek Vlg Ste A2, Cardiology Associates Of North Ms, Tupelo, MS 38801 Phone: 662-620-6800 Fax: 662-620-6920 |